Location History:
- Kanagawa, JP (2015)
- Saitama, JP (2017)
- Wako, JP (2019)
Company Filing History:
3 out of 854 
1 out of 90 
Years Active: 2015-2019
Title: Fumihiko Ishikawa: Innovator in Therapeutic Agents for Leukemia
Introduction
Fumihiko Ishikawa is a notable inventor based in Wako, Japan. He has made significant contributions to the field of medical research, particularly in developing therapeutic agents for leukemia. With a total of 3 patents to his name, Ishikawa's work is paving the way for advancements in cancer treatment.
Latest Patents
Ishikawa's latest patents include a therapeutic agent for intractable leukemia. This invention provides a therapeutic composition comprising a drug (a) and a drug (b), where drug (a) is a compound represented by a specific formula. Another significant patent focuses on an agent for treating or inhibiting the recurrence of acute myeloid leukemia. This invention includes a compound represented by a formula that targets leukemia stem cells, showcasing Ishikawa's innovative approach to combating this challenging disease.
Career Highlights
Throughout his career, Fumihiko Ishikawa has worked with esteemed organizations such as Riken Corporation and The Jackson Laboratory. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his research and development efforts.
Collaborations
Ishikawa has collaborated with notable coworkers, including Yoriko Saito and Yoshinobu Hashizume. These partnerships have contributed to the success of his research initiatives and the development of his patented inventions.
Conclusion
Fumihiko Ishikawa's contributions to the field of leukemia treatment through his innovative patents highlight his dedication to advancing medical science. His work continues to inspire future research and development in therapeutic agents for cancer.